Gluz, O., Nitz, U., Kreipe, H., Christgen, M., Kates, R., Hofmann, D., Shak, S., Clemens, M., Kraemer, S., Aktas, B., Kuemmel, S., Reimer, T., Kusche, M., Heyl, V., Lorenz-Salehi, F., Just, M., Liedtke, C., Wuerstlein, R., & Harbeck, N. (n.d.). 1937 Clinical impact of risk classification by central/local grade or luminal-like subtype vs. Oncotype DX®: First prospective survival results from the WSG phase III planB trial. European journal of cancer, 51, S311–. http://access.bl.uk/ark:/81055/vdc_100030628182.0x000026